Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 2
1986 3
1987 4
1988 2
1989 3
1990 5
1991 10
1992 9
1993 9
1994 18
1995 11
1996 9
1997 15
1998 19
1999 21
2000 22
2001 37
2002 29
2003 29
2004 48
2005 56
2006 60
2007 79
2008 86
2009 98
2010 114
2011 126
2012 173
2013 218
2014 245
2015 287
2016 278
2017 311
2018 348
2019 429
2020 483
2021 529
2022 609
2023 567
2024 579
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,319 results

Results by year

Filters applied: . Clear all
Page 1
Standards of medical care for type 2 diabetes in China 2019.
Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, Zou D, Guo L, Ji Q, Chen L, Chen L, Dou J, Guo X, Kuang H, Li L, Li Q, Li X, Liu J, Ran X, Shi L, Song G, Xiao X, Yang L, Zhao Z; Chinese Diabetes Society. Jia W, et al. Among authors: ji l. Diabetes Metab Res Rev. 2019 Sep;35(6):e3158. doi: 10.1002/dmrr.3158. Epub 2019 May 29. Diabetes Metab Res Rev. 2019. PMID: 30908791 Review.
SARS-CoV-2 RNA stabilizes host mRNAs to elicit immunopathogenesis.
Zhao H, Cai Z, Rao J, Wu D, Ji L, Ye R, Wang D, Chen J, Cao C, Hu N, Shu T, Zhu P, Wang J, Zhou X, Xue Y. Zhao H, et al. Among authors: ji l. Mol Cell. 2024 Feb 1;84(3):490-505.e9. doi: 10.1016/j.molcel.2023.11.032. Epub 2023 Dec 20. Mol Cell. 2024. PMID: 38128540
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial.
Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, Hadjadj S, Gillard P, Górriz JL, Idorn T, Ji L, Mahaffey KW, Perkovic V, Rasmussen S, Schmieder RE, Pratley RE, Tuttle KR. Mann JFE, et al. Among authors: ji l. Nat Med. 2024 Oct;30(10):2849-2856. doi: 10.1038/s41591-024-03133-0. Epub 2024 Jun 24. Nat Med. 2024. PMID: 38914124 Free PMC article. Clinical Trial.
CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.
Schnell O, Barnard-Kelly K, Battelino T, Ceriello A, Larsson HE, Fernández-Fernández B, Forst T, Frias JP, Gavin JR 3rd, Giorgino F, Groop PH, Heerspink HJL, Herzig S, Hummel M, Huntley G, Ibrahim M, Itzhak B, Jacob S, Ji L, Kosiborod M, Lalic N, Macieira S, Malik RA, Mankovsky B, Marx N, Mathieu C, Müller TD, Ray K, Rodbard HW, Rossing P, Rydén L, Schumm-Draeger PM, Schwarz P, Škrha J, Snoek F, Tacke F, Taylor B, Jeppesen BT, Tesfaye S, Topsever P, Vilsbøll T, Yu X, Standl E. Schnell O, et al. Among authors: ji l. Cardiovasc Diabetol. 2024 Mar 19;23(1):104. doi: 10.1186/s12933-024-02180-8. Cardiovasc Diabetol. 2024. PMID: 38504284 Free PMC article.
5,319 results